Skip to main navigation Skip to search Skip to main content

A Randomised, placebo controlled, parallel group, multi-centre, multi-national trial with a 16 week double blind period and 36 week open-label period

Project: Research

Project Details

StatusFinished
Effective start/end date11/11/15 → 11/10/21

Funding

  • Novo Nordisk Incorporated: $15,600.00